Prevention and Treatment of Papillomavirus-Related Cancers Through Immunization

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

(2010) S Daayana et al.   BRITISH JOURNAL OF CANCER

Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young Women

(2010) R. P. Insinga et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Multiplexed Serologic Assay for Nine Anogenital Human Papillomavirus Types

(2010) D. Opalka et al.   Clinical and Vaccine Immunology

HPV-Mediated Genome Instability: At the Roots of Cervical Carcinogenesis

(2010) E. Boccardo   CYTOGENETIC AND GENOME RESEARCH

IL-1 signalling determines the fate of skin grafts expressing non-self protein in keratinocytes

(2010) Usriansyah Hadis et al.   EXPERIMENTAL DERMATOLOGY

Current understanding of the mechanism of HPV infection

(2010) John T. Schiller et al.   GYNECOLOGIC ONCOLOGY

Evolution of type-specific immunoassays to evaluate the functional immune response to GARDASIL®, a vaccine for Human Papillomavirus types 16, 18, 6, and 11

(2010) Judith F. Smith et al.   Human vaccines & immunotherapeutics

Development of an HPV vaccine for a broad spectrum of high-risk types

(2010) Tadahito Kanda et al.   Human vaccines & immunotherapeutics

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

(2010) Sven-Eric Olsson et al.   Human vaccines & immunotherapeutics

Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

(2010) Mark H. Einstein et al.   Human vaccines & immunotherapeutics

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Genotype-Specific Clearance of Genital Human Papillomavirus (HPV) Infections among Mothers in the Finnish Family HPV Study

(2010) K. Louvanto et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads

(2010) H. Faust et al.   JOURNAL OF GENERAL VIROLOGY

Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58

(2010) S. A. Brendle et al.   JOURNAL OF GENERAL VIROLOGY

Antigen-Specific CD4 Cells Assist CD8 T-Effector Cells in Eliminating Keratinocytes

(2010) Jennifer K. Broom et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

(2010) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections

(2010) M. Safaeian et al.   JNCI-Journal of the National Cancer Institute

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

(2010) Basil Donovan et al.   LANCET INFECTIOUS DISEASES

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

(2010) K. Kian Ang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer

(2010) Sophia S. Wang et al.   PLoS One

Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model

(2010) Holly J. Corbett et al.   PLoS One

Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes

(2010) Johanna Palmroth et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

(2010) Subhashini Jagu et al.   VACCINE

Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7

(2010) Jerri do Carmo Caldeira et al.   VACCINE

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

(2010) Hans-Ulrich Bernard et al.   VIROLOGY

Mechanisms of cell entry by human papillomaviruses: an overview

(2010) Caroline AJ Horvath et al.   Virology Journal

Viral-Associated Nonmelanoma Skin Cancers: A Review

(2009) Meghan Dubina et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants

(2009) S. S. Wang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

(2009) S. K. Kjaer et al.   Cancer Prevention Research

Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-α

(2009) Enrique Boccardo et al.   CARCINOGENESIS

The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production

(2009) Elvire Bourgeois et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The role of furin in papillomavirus infection

(2009) Patricia M Day et al.   Future Microbiology

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆

(2009) Marie-Pierre David et al.   GYNECOLOGIC ONCOLOGY

Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia

(2009) Koenraad Van Doorslaer et al.   GYNECOLOGIC ONCOLOGY

Cancer incidence and risk factors after solid organ transplantation

(2009) Claire M. Vajdic et al.   INTERNATIONAL JOURNAL OF CANCER

CD207+CD103+dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells

(2009) Sandrine Henri et al.   JOURNAL OF EXPERIMENTAL MEDICINE

IFN-  Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host

(2009) X. S. Liu et al.   JOURNAL OF IMMUNOLOGY

Invariant NKT Cells in Hyperplastic Skin Induce a Local Immune Suppressive Environment by IFN-  Production

(2009) S. R. Mattarollo et al.   JOURNAL OF IMMUNOLOGY

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Hear All About It

(2009) Lorraine S. Wallace et al.   Journal of Lower Genital Tract Disease

Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines

(2009) S. Bellone et al.   JOURNAL OF VIROLOGY

Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines

(2009) C. Schellenbacher et al.   JOURNAL OF VIROLOGY

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE

The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding

(2009) R. C. Kines et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women

(2009) C K Fairley et al.   SEXUALLY TRANSMITTED INFECTIONS

Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence

(2009) Paolo Bonanni et al.   VACCINE

Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far

(2009) Theodoros Agorastos et al.   VACCINE

Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine

(2009) Ali Rowhani-Rahbar et al.   VACCINE

The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix

(2009) Paulo Cesar Maciag et al.   VACCINE

Anaphylaxis following quadrivalent human papillomavirus vaccination

(2008) J. M.L. Brotherton et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Seroreactivity to Cutaneous Human Papillomaviruses among Patients with Nonmelanoma Skin Cancer or Benign Skin Lesions

(2008) K. Andersson et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Clinical and Immunologic Results of a Phase II Trial of Sequential Imiquimod and Photodynamic Therapy for Vulval Intraepithelial Neoplasia

(2008) U. Winters et al.   CLINICAL CANCER RESEARCH

A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3

(2008) C. L. Trimble et al.   CLINICAL CANCER RESEARCH

Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of age

(2008) Diane M. Harper   GYNECOLOGIC ONCOLOGY

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells

(2008) M. D. Smithgall et al.   INTERNATIONAL IMMUNOLOGY

Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia

(2008) Muriel van den Hende et al.   INTERNATIONAL JOURNAL OF CANCER

Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: A case-control study

(2008) Anita S. Patel et al.   INTERNATIONAL JOURNAL OF CANCER

Betapapillomaviruses: Innocent bystanders or causes of skin cancer

(2008) Mariet C.W. Feltkamp et al.   JOURNAL OF CLINICAL VIROLOGY

Common Variants in Immune and DNA Repair Genes and Risk for Human Papillomavirus Persistence and Progression to Cervical Cancer

(2008) Sophia S. Wang et al.   JOURNAL OF INFECTIOUS DISEASES

Detection of Human Papillomavirus DNA in Cutaneous Squamous Cell Carcinoma among Immunocompetent Individuals

(2008) Maryam M. Asgari et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human Papillomavirus

(2008) K. M. Johnson et al.   JOURNAL OF VIROLOGY

Intrafamilial Transmission and Family-Specific Spectra of Cutaneous Betapapillomaviruses

(2008) S. J. Weissenborn et al.   JOURNAL OF VIROLOGY

Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies

(2008) P. M. Day et al.   JOURNAL OF VIROLOGY

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

(2008) Margaret RE McCredie et al.   LANCET ONCOLOGY

Evolving immunosuppressive microenvironment during human cervical carcinogenesis

(2008) A Kobayashi et al.   Mucosal Immunology

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

(2008) Stephanie C. Eisenbarth et al.   NATURE

Natural History of Human Papillomavirus Infections, Cytologic and Histologic Abnormalities, and Cancer

(2008) Cosette Marie Wheeler   OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA

Clathrin- and Caveolin-Independent Entry of Human Papillomavirus Type 16—Involvement of Tetraspanin-Enriched Microdomains (TEMs)

(2008) Gilles Spoden et al.   PLoS One

Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

(2008) F. Xavier Bosch et al.   VACCINE

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

(2008) Elmar A. Joura et al.   VACCINE

Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report

(2008) David Yiu-Kuen But et al.   VACCINE

Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions

(2008) Anna R. Giuliano et al.   VACCINE

Seroprevalence of 34 Human Papillomavirus Types in the German General Population

(2008) Kristina M. Michael et al.   PLoS Pathogens

TLR7 stimulation augments T effector-mediated rejection of skin expressing neo-self antigen in keratinocytes

(2007) Jie Zhong et al.   EUROPEAN JOURNAL OF IMMUNOLOGY